Biogen Wants MS Drug Approved Globally, CEO Says

April 15 (Bloomberg) -- George Scangos, chief executive officer of Biogen Idec Inc., talks about the drugmaker's first multiple sclerosis pill Tecfidera and the company's drug pipeline. He speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)

Was the DNC Hack Preventable?
46:01 - Eric O'Neill, Carbon Black's national security strategist, discusses how to respond to government hacks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • Will Berlin Become Europe's Top Tech Hub?
  • Full Show: Best of Bloomberg Markets Middle East (07/29)
  • Talend CEO: Why We Decided to Go Public Now